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Intracranial fungal granulomas are rare and of the histologically veriﬁed granulomas, Aspergillus spp. is the commonest causative
fungal pathogen. Most of the reported large series of aspergillus granulomas are from countries with temperate climate like India,
Pakistan, Sudan, and Saudi Arabia. In contrast to disseminated aspergillosis that occurs in immunosuppressed individuals, most
of the intracranial aspergillus granulomas are reported in immunocompetent individuals. The temperature, humidity, high spore
content in the atmosphere during ploughing, and occupation as agricultural worker are implicated in the pathogenesis. The
sinocranial spread is the most common route of intracranial extension. Extracerebral ﬁrm ﬁbrotic lesions and skull base lesions
are common. Extensive ﬁbrosis and large number of multinucleated giant cells are the characteristic histological features and these
pathological features have therapeutic relevance.
1.Introduction
Fungal infections of the central nervous system (CNS) are
more frequently reported in the last few decades mostly
due to increase in the population at risk, increased aware-
ness, and better diagnostic modalities [1–4]. However, in
the recent years there has been increase in the number
of CNS fungal infections in immunocompetent individuals
[2–12].
Fungi are ubiquitous in nature but have low virulence
andcausediseaseusuallywhenthehostdefensesarecompro-
mised.ThefungientertheCNSbyhematogenousroutefrom
the systemic focus, or by contiguous spread from paranasal
sinuses (PNS), ear or skull bone; or by direct inoculation
during trauma or surgical procedure [1–5]. The pathology
depends upon the route of spread, host immunity, and type
of fungus, hyphae, or yeast.
The fungi may involve any part of the neuroaxis, and the
pathology includes meningitis, encephalitis, abscess, gran-
uloma, and vasculitis with associated infarction and hem-
orrhage and aneurysmal formation [1–4, 13]. The type of
pathology, to some extent, determines the presenting clinical
manifestations. This paper will discuss the experience with
intracranial Aspergillus granuloma.
2. Epidemiology
The incidence of CNS fungal infections parallels the inci-
dence of systemic fungal infections. The estimated annual
incidences of invasive fungal infections caused by Aspergillus
species are 12–34 [17]. The reported incidence of CNS
involvement associated with invasive aspergillosis is about 4–
6% [18]. Intracranial Aspergillus granulomas are rare space
occupying intracranial lesions [2–4, 7, 9, 11, 13, 16–21]a n d
most of the reported large series are from countries with
temperate climate like India, Pakistan, Sudan, and Saudi
Arabia [2–4, 6–8, 10, 12–14, 16–26].
Among the intracranial fungal granulomas, Aspergillus
granuloma is the most commonly reported granuloma [2–
4, 13, 14, 20–25]( Table 1). The prevalence of intracranial
fungal mass lesions in major neurosurgical centers in India is
around one to two per years [27], and Aspergillus spp. is the
commonest causative fungal pathogen accounting for 56%
to 69% of the intracranial fungal mass lesions [2, 19, 20],2 Pathology Research International
Table 1: Intracranial Aspergillus granulomas.
Kak et al. 1989
[14]
Camarata et al.
1992 [15]
Naim-Ur-
Rahman et al.
1996 [16]
Murthy et al.
2001 [7]
Alrajhi et al.
2001 [6]
Siddiqui et al.
2004 [8]
Sundaram et al.
2006 [2]
Number 62 13 9 21 23 35 130
Age in years 12–48 26–66 19–65 9–. 61 14–74 5–75
M: F NA NA 1:08 10:06 14:09 23:02 1.8:1
Predisposing
Factors Nil Nil Nil DM-2 DM-4 Nil Nil
Route of
spread
Sino-orbital 10
Hematogenous
52
Sinocranial 9
Hematogenous
4
Sinocranial 9 Sinocranial 16 Sinocranial 9 Sinonasal 35
Sinocranial 103
Hematogenous
20
Others 7
Pathology Granulomas 28
Disseminated 34
Granulomas 12
Disseminated 01 Granulomas 9 Granulomas 16
Disseminated 5 Granulomas 23 NA Granulomas 68
Culture 9 NA — A. ﬂavus 4
A. fumigatus 2
A. ﬂavus 15
A. fumigatus 2 15
A. ﬂavus 10
A. fumigatus 5
A. niger 2
A. terreus 1
Sterile 3
N A :N o ta v a i l a b l e ,D M :D i a b e t e sM e l l i t u s .
Table 2: Intracranial fungal granuloma: series from temperate climate.
Anandi et al. 1993
[25] Santosh et al. 1996 [3] Dubey et al. 2005 [20] Sundaram et al. 2006
[2]
n 4/41 15/65 40 74/130
Occupation NA Agricultural worker NA Agricultural worker,
Manual labourer
Organism Aspergillus (4)
Aspergillus 10
Cryptococcus 2
Phaeohyphomycosis 3
Aspergillus 25
Cryptococcus 3
Phaeohyphomycosis 4
Zygomycosis 7
Candidiasis 1
Aspergillus 68
Cryptococcus 1
Phaeohyphomycosis 1
Zygomycosis 1
Candidiasis 2
Mixed 1
n: Number of cases, NA: Not Available.
whereas it was the causative fungus in 5% of the fungal mass
lesions in the series from USA [28]( Table 2).
3. Pathogenesis
Aspergillus spp. are the most clinically signiﬁcant moulds
and are ubiquitous throughout the world. They are present
in soil, water, decaying vegetation, and organic debris. A.
fumigatus causes most disease followed by A. ﬂavus and A.
terreus. A. ﬂavus is the commonest agent when the infection
extends from PNS to CNS [1–4].
Brain is remarkably resistant to fungal infections due to
the abundant blood supply and also due to the relatively
impermeable blood-brain barrier. Despite the fact that the
brain and subarachnoid space are protected by anatomic and
functional barriers, under special conditions and immune
system abnormalities, fungal pathogens breach these barriers
[29]. Invasive disease is seen mostly in patients who are
signiﬁcantly immunocompromised: patients with prolonged
neutropenia, hematological malignancies or advanced AIDS,
and hematopoietic stem cell transplant and solid organ
transplant [30, 31]. However, Aspergillus granulomas in
countries with temperate climates are most commonly
reported in immunocompetent individuals [2, 7, 13].
Aspergillus moulds enter the CNS by hematogenous
route from the systemic focus, mostly from the lung or by
contiguous spread from paranasal sinuses (PNS), ear or skull
bone or by direct inoculation during trauma or surgical
procedure [1–5]. The sinocranial form of CNS aspergillosis
is often reported from countries with temperate climate [2,
7, 13]. In countries with temperate climate, the temperature
and humidity favor the growth of the fungus. Ploughing
during agriculture works or construction activities results in
aerosolization of number of spores into the environment.
High spore content in the atmosphere exposes the
agriculture workers and workers in the construction activity
to inhale the fungal spores.
Thesporesarecolonizedinthelungs,nose,PNS,mastoid
air cells, and ear canal. Closed cavity and anaerobic atmo-
sphere promote growth of the fungus. There may be localPathology Research International 3
Figure 1: Contrast CT scans showing densely enhancing left temporal intraparenchymal Aspergillus granuloma (a) and enhancing mass
lesion in the ethmoid sinuses, right orbital apex, right extraparenchymal temporall fossa and left cavernous sinus skull base Aspergillus
granuloma (b).
(a) (b)
Figure 2: Histological sections of Aspergillus granuloma. (a) Giant cell rich granulomas with dense ﬁbrosis (H&E; X40). (b) Giant cell with
intracytoplasmic negative staining hyphae (H&E; X200). Inset: Gomori’s silver methenamine stain highlighting slender septate hyphae of
Aspergillus spp. (GMS; X400).
altered immunity which promotes the mucosal invasion of
the fungus [1–4]. The immunopathogenesis of CNS fungal
infections remains incompletely studied, with most of the
knowledge coming from studies on experimentally infected
animals. The activation of brain resident cells such as mi-
croglia, astrocytes, and endothelial cells combined with rel-
ative expression of immune-enhancing and immune-sup-
pressing cytokines and chemokines may play a determinant
role in immunopathogenesis [29].
4.Pathology
Mostly these lesions, because of the sinocranial spread of the
infection, are extraparenchymal and skull base in location.
Skull base location includes anterior and middle cranial
fossae, orbit, orbital apex, cavernous sinus, and rarely pos-
terior fossa (Figure 1). Rarely these lesions can be primarily
intraparenchymal, involving frontal and temporal lobes [19,
21]. The location of the lesions probably explains the clin-
ical syndromes. Histologically the granulomas show dense
ﬁbrosis and an inﬁltrate of lymphocytes, plasma cells, and
mononuclear cells. The multinucleate giant cells are foreign
body type and contain slender septate, acute angle branching
hyphae of Aspergillus spp. The extracerebral granulomas dif-
fer from intraparenchymal granulomas in having extensive
ﬁbrosis [19–21]. Aspergillus granuloma on haematoxylin and
eosin staining sometimes may be mistaken for tuberculous
granuloma. However, the prominence of multinucleated
giant cells with admixture of neutrophils, plasma cells and
eosinophils and relatively less number of epitheloid cells
diﬀerentiates tuberculous granuloma from Aspergillus gran-
uloma. Good scanning of the biopsy may reveal fungal hyph-
ae within giant cells.
Gomori’s methenamine silver (GMS) and Periodic Acid
Schiﬀ (PAS) stains demonstrate the slender septate hyphae
with acute angle branching of the Aspergillus spp. in4 Pathology Research International
Aspergillus granuloma [19–21]( Figure 2). The extensive
ﬁbrosis observed in the extraparenchymal, sinocranial As-
pergillus granulomas has therapeutic relevance. Extensive ﬁ-
brosis does not allow eﬀective penetration of systemically
administered antifungal agents. Thus these lesions need ex-
tensive radical excision to achieve cure [16, 19]. The other
approach to achieve eﬀective therapeutic concentration of
the antifungal agents will be intralesional administration of
the antifungal agents by Ommaya reservoir [16, 19]. The pa-
thology of haematogenous dissemination to CNS, because
of angioinvasive character of Aspergillus, includes ischemic
infarction and haemorrhage, and the pathology in the sino-
cranial aspergillosis is characterized by well-formed granu-
loma [2].
5.SinocranialAspergillus
Granuloma—Pathological
Features—TherapeuticRelevance
A. fumigatus elaborates a substance called fumagillin which
is responsible for ﬁbrosis [13]. Many allergens present in
A. fumigatus are present at high levels of homology in A.
ﬂavus. A. ﬂavus causes majority of the sinocranial infections.
A. ﬂavus produces many more allergic proteins than the two
currently known proteins (Asp ﬂ 13 and Asp ﬂ 18) and may
possessanallergencomponentsimilartothatofA.fumigatus
[35].A .ﬂ a v u sseems to be more virulent and more resistant
toantifungaldrugsthanmostoftheotherAspergillus species.
The extensive ﬁbrosis observed in the extraparenchymal,
sinocranialAspergillusgranulomashastherapeuticrelevance.
Extensive ﬁbrosis does not allow eﬀective penetration of sys-
temically administered antifungal agents. Thus these lesions
need extensive radical excision to achieve cure [8, 16, 19,
30, 32]. The other approach to achieve eﬀective therapeutic
concentration of the antifungal agents will be intralesional
administrationoftheantifungalagentsbyOmmayareservoir
[7, 15, 33].
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